CORMORANT ASSET MANAGEMENT, LP – X4 Pharmaceuticals, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$1.42M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+77.20%
quarter
X4 Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +698.86% | 726.67K shares | 1.32M | $1.71 | 830.65K |
| Q2 2022 | share | 0.00% | 0 shares | -82K | $0.97 | 103.98K | |
| Q1 2022 | share | 0.00% | 0 shares | -56K | $1.75 | 103.98K | |
| Q4 2021 | share | 0.00% | 0 shares | -312K | $2.27 | 103.98K | |
| Q3 2021 | share | 0.00% | 0 shares | -126K | $5.29 | 103.98K | |
| Q2 2021 | share | 0.00% | 0 shares | -219K | $6.5 | 103.98K | |
| Q1 2021 | share | 0.00% | 0 shares | 226K | $8.61 | 103.98K | |
| Q4 2020 | share | Increase | 0.00% | 103.98K shares | 669K | $6.43 | 103.98K |
| Q3 2020 | share | Decrease | -100.00% | -328.98K shares | -1.75M | $6.77 | 0 |
| Q2 2020 | share | Decrease | -3.70% | -12.63K shares | -1.65M | $9.32 | 328.98K |
| Q1 2020 | share | Increase | +35.16% | 88.87K shares | 712K | $10 | 341.61K |
| Q4 2019 | share | Decrease | -71.33% | -628.93K shares | -8.50M | $10.7 | 252.74K |
| Q3 2019 | share | Decrease | -0.98% | -8.70K shares | -2.15M | $12.71 | 881.68K |
| Q2 2019 | share | Increase | +252.28% | 637.63K shares | 8.95M | $15 | 890.38K |
| Q1 2019 | share | Increase | 0.00% | 252.74K shares | 4.4M | $17.41 | 252.74K |